Folgen
Brian J.A. Gill
Brian J.A. Gill
Department of Neurosurgery - Columbia University Medical Center/New York Presbyterian Hospital
Bestätigte E-Mail-Adresse bei columbia.edu
Titel
Zitiert von
Zitiert von
Jahr
MRI-localized biopsies reveal subtype-specific differences in molecular and cellular composition at the margins of glioblastoma
BJ Gill, DJ Pisapia, HR Malone, H Goldstein, L Lei, A Sonabend, J Yun, ...
Proceedings of the National Academy of Sciences 111 (34), 12550-12555, 2014
2792014
A multiparametric model for mapping cellularity in glioblastoma using radiographically localized biopsies
PD Chang, HR Malone, SG Bowden, DS Chow, BJA Gill, TH Ung, ...
American Journal of Neuroradiology 38 (5), 890-898, 2017
1042017
Multiscale recordings reveal the dynamic spatial structure of human seizures
CA Schevon, S Tobochnik, T Eissa, E Merricks, B Gill, RR Parrish, ...
Neurobiology of disease 127, 303-311, 2019
512019
Murine cell line model of proneural glioma for evaluation of anti-tumor therapies
AM Sonabend, J Yun, L Lei, R Leung, C Soderquist, C Crisman, BJ Gill, ...
Journal of neuro-oncology 112, 375-382, 2013
452013
Sodium fluorescein facilitates guided sampling of diagnostic tumor tissue in nonenhancing gliomas
SG Bowden, JA Neira, BJA Gill, TH Ung, ZK Englander, G Zanazzi, ...
Neurosurgery 82 (5), 719-727, 2018
382018
Chronic convection-enhanced delivery of topotecan for patients with recurrent glioblastoma: a first-in-patient, single-centre, single-arm, phase 1b trial
EF Spinazzi, MG Argenziano, PS Upadhyayula, MA Banu, JA Neira, ...
The Lancet Oncology 23 (11), 1409-1418, 2022
222022
Local glioma cells are associated with vascular dysregulation
SG Bowden, BJA Gill, ZK Englander, CI Horenstein, G Zanazzi, PD Chang, ...
American Journal of Neuroradiology 39 (3), 507-514, 2018
172018
Fluorescein-guided resection of gliomas.
AV Save, BJ Gill, RS D'amico, P Canoll, JN Bruce
Journal of Neurosurgical Sciences 63 (6), 648-655, 2019
132019
Neurosurgery case review: questions and answers
R Nader, AJ Sabbagh
Georg Thieme Verlag, 2020
102020
Synaptic hyperexcitability of cytomegalic pyramidal neurons contributes to epileptogenesis in tuberous sclerosis complex
X Wu, AA Sosunov, W Lado, JJ Teoh, A Ham, H Li, O Al-Dalahmah, ...
Cell reports 40 (3), 2022
92022
MGMT Promoter Methylation Predicts Overall Survival after Chemotherapy for 1p/19q-Codeleted Gliomas
CJ Kinslow, AI Rae, K Taparra, P Kumar, MD Siegelin, J Grinband, ...
Clinical Cancer Research 29 (21), 4399-4407, 2023
82023
Re-convolving the compositional landscape of primary and recurrent glioblastoma reveals prognostic and targetable tissue states
O Al-Dalahmah, MG Argenziano, A Kannan, A Mahajan, J Furnari, ...
Nature Communications 14 (1), 2586, 2023
82023
Ex vivo multi-electrode analysis reveals spatiotemporal dynamics of ictal behavior at the infiltrated margin of glioma
BJA Gill, X Wu, FA Khan, AA Sosunov, J Liou, A Dovas, TL Eissa, ...
Neurobiology of disease 134, 104676, 2020
82020
Single unit analysis and wide-field imaging reveal alterations in excitatory and inhibitory neurons in glioma
BJA Gill, FA Khan, AR Goldberg, EM Merricks, X Wu, AA Sosunov, ...
Brain 145 (10), 3666-3680, 2022
72022
Superficial temporal artery pseudoaneurysm following trigeminal nerve stimulator placement
JA Ellis, BJ Gill, D Pisapia, CJ Winfree
Neuromodulation 17 (8), 788-790, 2014
32014
You're Not Hallucinating: Potential New Targets for Schizophrenia Treatment
BJA Gill, FA Khan, GM McKhann
Neurosurgery 84 (3), E146-E147, 2019
22019
Balloon-and stent-assisted endovascular occlusion of intracranial aneurysms
BJA Gill, JA Ellis, PM Meyers
Cerebrovascular and Endovascular Neurosurgery: Complication Avoidance and …, 2018
22018
Glioma-Induced Alterations in Excitatory Neurons are Reversed by mTOR Inhibition
AR Goldberg, A Dovas, D Torres, S Das Sharma, A Mela, EM Merricks, ...
bioRxiv, 2024.01. 10.575092, 2024
2024
Autologous cell immunotherapy (IGV-001) with IGF-1R antisense oligonucleotide in newly diagnosed glioblastoma patients
IY Lee, S Hanft, M Schulder, KD Judy, ET Wong, JB Elder, LT Evans, ...
Future Oncology, 2023
2023
A randomized, multicenter, double-blind, phase 2b study of IGV-001, an autologous cell immunotherapy with antisense oligo IMV-001 targeting IGF-1R, vs placebo, in newly …
I Lee, K Judy, M Schulder, S Hanft, L Evans, J Wu, S Aulakh, E Wong, ...
NEURO-ONCOLOGY 25, 2023
2023
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20